FDA Approved: PREGABALIN — Supplemental Application (Creekwood Pharmaceuticals LLC)

View source ↗

Summary

The FDA approved a supplemental application for pregabalin from Creekwood Pharmaceuticals LLC under ANDA213423.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diabetic Peripheral Neuropathy
• Epilepsy
• Fibromyalgia
• Generalized Anxiety Disorder
• Postherpetic Neuralgia

Drugs mentioned

• Pregabalin (Pregabalin)

Snippet

SUPPL AP for PREGABALIN (PREGABALIN)